SEC Form 4 · accession 0000899243-19-000655
INFINITY PHARMACEUTICALS, INC. · INFI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffery Kutok
Officer — Chief Scientific Officer
Period of report
Jan 4, 2019
Accepted (ET)
Jan 7, 2019 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113148
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.24 | Jan 4, 2019 | A | 155,000 | A | — | Jan 4, 2029 | Common Stock | 155,000 | 155,000 | D |
Explanation of responses
- F1The option vests as to 1/48th of the shares on January 31, 2019 and vests as to 1/48th of the shares at the end of each calendar month thereafter.